Metastatic malignant disease of unknown primary origin – NICE guideline – 26 July 2010

Posted on July 27, 2010. Filed under: Oncology | Tags: |

NICE guideline set to transform cancer care for thousands of patients 

Media release:
“From today (26 July), specialist cancer teams will be tasked with improving the care and treatment of patients whose cancer has spread to other parts of the body from an unknown primary location. The re-organisation of cancer services for this group of patients is one of a raft of measures being recommended by the National Institute for Health and Clinical Excellence (NICE) to tackle the current inequality in care these patients often receive compared with people who have a site-specific type of cancer such as breast, lung or prostate.

This guideline has received the support of the National Cancer Peer Review Programme in England, which is studying the recommendations to develop a number of peer review measures. These are ‘quality measures’ that hospitals are required to follow and are assessed against with the aim of improving care for cancer patients and their families.”


The Guideline:
Metastatic malignant disease of unknown primary origin: Diagnosis and management of metastatic malignant disease of unknown primary origin

The advice in the NICE guideline covers: the treatment and care of adults with suspected or diagnosed cancer of unknown primary, including people who have been treated for cancer before.”


Make a Comment

Leave a Reply

Please log in using one of these methods to post your comment: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

Liked it here?
Why not try sites on the blogroll...

%d bloggers like this: